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ABSTRACT
Among bacterial topoisomerase I enzymes, a con-
served methionine residue is found at the active
site next to the nucleophilic tyrosine. Substitution
of this methionine residue with arginine in recombi-
nant Yersinia pestis topoisomerase I (YTOP) was the
only substitution at this position found to induce the
SOS response in Escherichia coli. Overexpression
of the M326R mutant YTOP resulted in ~4 log loss
of viability. Biochemical analysis of purified Y. pestis
and E. coli mutant topoisomerase I showed that
the Met to Arg substitution affected the DNA religa-
tion step of the catalytic cycle. The introduction of
an additional positive charge into the active site
region of the mutant E. coli topoisomerase I activity
shifted the pH for optimal activity and decreased the
Mg
2+ binding affinity. This study demonstrated that
a substitution outside the TOPRIM motif, which
binds Mg
2+directly, can nonetheless inhibit Mg
2+
binding and DNA religation by the enzyme, increas-
ing the accumulation of covalent cleavage complex,
with bactericidal consequence. Small molecules
that can inhibit Mg
2+ dependent religation by bac-
terial topoisomerase I specifically could be devel-
oped into useful new antibacterial compounds.
This approach would be similar to the inhibition
of divalent ion dependent strand transfer by HIV inte-
grase in antiviral therapy.
INTRODUCTION
DNA topoisomerases are ubiquitous enzymes that aﬀect
many vital cellular processes by controlling the level of
DNA supercoiling and removing the tangling of DNA
strands via the concerted cleavage and religation of DNA
strands (1–4). Besides playing important roles in removing
topological barriers from DNA, these enzymes are also
highly relevant targets for anticancer and antibacterial
therapy, because compounds that act as topoisomerase
poisons can increase the accumulation of the covalent
intermediates formed between topoisomerases and cleaved
DNA, leading to cell death (5–8). The ability to combat
bacterial infection has been seriously challenged by the
rapid development of bacterial pathogens that are resistant
to all commonly used antibiotics, including ﬂuoroquino-
lones that target type IIA topoisomerases (8–11).
Type IA topoisomerases represent a promising new
target for development of a novel class of antibiotics
(12,13). All DNA topoisomerases utilize the hydroxyl
group of an active site tyrosine side chain in the nucleo-
philic attack of the DNA phosphodiester backbone to
form the covalent intermediate with the cleaved DNA
(4). Type IA and type IIA topoisomerases utilize the
TOPRIM DXDXXG motif found in many examples of
nucleotidyl transferases (14) to coordinate two Mg
2+ ions
in the active site for catalytic activity. For type IA topo-
isomerases, Mg
2+addition is not required for DNA
cleavage, but Mg
2+ addition is required for the DNA
religation step (15,16). Mutation of the conserved Gly
residue in the bacterial topoisomerase I TOPRIM motif
to Ser has been shown to inhibit DNA religation and was
identiﬁed by induction of the dinD1::lacZ reporter upon
expression of recombinant Y. pestis topoisomerase I with
this mutation (17). Following DNA damage in E. coli,
RecA protein activated by ﬁlament formation with
single-stranded DNA interacts with the LexA repressor
and stimulates LexA autoproteolysis, resulting in induc-
tion of the SOS regulon, including the dinD1 gene, nor-
mally repressed by LexA binding to its operator sequence.
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expression of the recombinant Gly to Ser mutant topo-
isomerase I proves that accumulation of cleavage complex
from type IA topoisomerases is bactericidal and validates
bacterial topoisomerase I as a target for identiﬁcation of
novel antibacterial compounds (12).
A second mutation in bacterial topoisomerase I, with
the Met residue that immediately follows the active site
tyrosine changed to Val, has been previously found to
have no SOS induction or bactericidal eﬀect on its own,
but can enhance the cell killing by the TOPRIM Gly to
Ser mutation due to the increase in DNA cleavage (18).
In this study, all possible substitutions at this position
that directly follows the active site tyrosine were exam-
ined in vivo using recombinant Y. pestis topoisomerase
I (YTOP) to determine if any of the mutant YTOP pro-
teins could induce the SOS response because of possible
eﬀect of the mutation on DNA religation. The M326R
substitution was the only one found to be able to induce
the SOS response from the dinD1 promoter (19). Detailed
biochemical analysis of the puriﬁed recombinant Y. pestis
topoisomerase I mutant YTOP-M326R and the corre-
sponding E. coli topoisomerase I mutant ETOP-M320R
protein showed that signiﬁcant DNA cleavage by these
mutant topoisomerase proteins required the addition of
Mg
2+. More critically, DNA religation and DNA relaxa-
tion activities were found to be reduced by this Met to Arg
substitution. The shift of optimal pH for relaxation activ-
ity to higher values and the reduction of measured Mg
2+
binding aﬃnity as a result of the mutation indicated that
Mg
2+ dependent DNA religation was compromised by
the introduction of an additional positive charge into the
active site region. This result has signiﬁcant implication
for the screening and design of novel antibacterial com-
pounds that can cause cell death by inhibiting the religa-
tion of the bacterial topoisomerase IA cleavage complex.
MATERIALS AND METHODS
Recombinant topoisomerase I
Recombinant Y. pestis topoisomerase I mutants with all
possible substitutions at Met326 were generated by site-
directed mutagenesis using the Pfu Ultra DNA polymerase
(from Stratagene) and pYTOP derived from pBAD/Thio
(17) as template. Mutants were obtained ﬁrst by utilizing
an oligonucleotide pair with mixed nucleotides at the
codon for Met326, and then with speciﬁc oligonucleotides
designed for substitutions not identiﬁed from the random
pool of mutants sequenced. The mutant pYTOP plasmids
were ﬁrst isolated in E. coli NEB Turbo competent cells
(from New England Biolabs) and then introduced after
sequence conﬁrmation into E. coli strain JD5 (20) with
the dinD1::lacZ fusion (19). Transformants were isolated
and maintained on LB plates with 100mg/ml ampicillin
and 2% glucose to suppress the expression of YTOP pro-
tein from the BAD promoter. Protein expression in JD5
was induced by addition of 0.02% arabinose to exponen-
tial phase culture in LB medium and the cells were har-
vested after 4h. The recombinant Y. pestis topoisomerase
I proteins with the C-terminus hexahistidine tag were
puriﬁed using the ProPur IMAC Midi spin column
(Nunc). After addition of the soluble lysate, the column
was ﬁrst washed with 30 column volume of PBS buﬀer
(59mM sodium phosphate pH 7.4, 300mM NaCl) with
30mM imidazole, then with 1 column volume each of
PBS buﬀer with 50 and 100mM imidazole. The topoisom-
erase I proteins was eluted with 1 column volume of PBS
buﬀer with 200mM imidazole, then 2 column volume PBS
buﬀer with 500mM imidazole.
The E. coli ETOP-M320R topoisomerase I mutant
clone was generated by site-directed mutagenesis using
pLIC-ETOP as template. The pLIC-ETOP plasmid was
made by ligation-independent cloning (21) of ETOP
coding sequence into a vector that allows T7 RNA poly-
merase dependent expression along with a tobacco etch
virus (TEV) protease-cleavable N-terminal hexahistidine
tag (22). Expression of the recombinant ETOP was
induced in E. coli BL21AI (from Invitrogen) by the addi-
tion of 0.02% arabinose and 1mM IPTG to exponential
phase LB culture. The recombinant protein in the soluble
lysate was allowed to bind to Ni-NTA agarose (Qiagen) in
PBS buﬀer pH 8.0 with 10mM imidazole which was then
packed into a column. After extensive washing, the topo-
isomerase protein was eluted with buﬀer containing
250mM imidazole, cleaved with TEV protease, and
passed through the Ni-NTA agarose again to remove
the histidine tag. Final puriﬁcation was carried out with
a single-stranded DNA cellulose column as described (23).
Expression plasmids were isolated from the induced
cultures during protein expression for sequencing of the
entire coding region of the recombinant topoisomerase
I molecule to ensure that no other mutation was present
in the polypeptide.
SOS induction and cell killing assays
Plasmid pYTOP derivatives expressing mutant YTOP
proteins under the control of the BAD promoter were
transformed into E. coli JD5 with the chromosomal
dinD1::lacZ fusion. SOS-inducing mutants were identiﬁed
as blue colonies by replica plating the transformants onto
X-gal plate with 100mg/ml ampicillin and 0.002% arabi-
nose as previously described (18). To measure the eﬀect of
mutant YTOP expression on viability, early exponential
phase culture of JD5 transformants in LB medium with
ampicillin (100mg/ml) was induced with 0.2% arabinose
for 2h before serial dilution and plating on LB plates with
2% glucose and ampicillin, followed by overnight incuba-
tion at 37
8C. The number of colonies obtained from the
induced culture was divided by the number of colonies
from the control non-induced culture to calculate the sur-
vival ratio.
Topoisomerase activity assays
DNA relaxation activity of each mutant topoisomerase
was compared with the wild-type topoisomerase by the
amount of enzyme in serial dilutions needed to observe
similar distribution of partially relaxed topoisomers from
the supercoiled DNA substrate. The relaxation activity
assay was carried out ﬁrst at pH 8.0 or then at diﬀerent
pH values as described (24). DNA cleavage activity was
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oligonucleotide substrate and rejoining of the cleavage
product was assessed by the addition of high salt to the
DNA cleavage reaction (18,25). The level of DNA cleav-
age products was analyzed after electrophoresis in a 15%
sequencing gel with the PhosphoImager Storm 860. To
quantitate the percent DNA cleavage product present,
the PhosphoImager signals for the cleavage product and
uncleaved substrate in each lane were added to obtain the
total substrate signal and control for any diﬀerence in
loading.
Mg
2+ binding by wild-type ETOP and ETOP-M320R
proteins was assessed by following the decrease in intrinsic
tryptophan ﬂuorescence emission upon titration of topo-
isomerase I protein with MgCl2 using the CARY Eclipse
ﬂuorescence spectrophotometer (17). The fraction of
maximal decrease in ﬂuorescence signal observed at each
Mg
2+ concentration was curve ﬁtted for two binding
sites in each enzyme molecule with the GraphPad
Prism software.
Molecular modeling
The Met to Arg substitution was introduced into the
structure of the N-terminal fragment of E. coli topoisom-
erase I (1ECL in Protein Data Bank) with the Mutate
function of DeepView-Swiss PDB Viewer (26). The argi-
nine rotamer that had a negative score, indicating that it
corresponded to a favorable conformation, was selected
for energy minimization. The minimized structure was
used to generate the electrostatic potential map with a
solvent dielectric constant of 80.
RESULTS
Substitution ofMet326 inYTOP withArg resulted
inSOS induction and cell killing
All possible substitution mutants of Met326 in YTOP were
examined in vivo using E. coli strain JD5 for the ability to
illicit the SOS response when mutant YTOP expression
was induced by a low level of arabinose (0.002%).
The M326R substitution was the only one found to
induce the SOS response from the dinD1 promoter.
Measurement of ratio of the number of viable colonies in
culture induced by a higher level of arabinose (0.2%)
versus the number of colonies in the non-induced cultures
was carried out for most of the substitution mutants
to conﬁrm that the SOS induction phenotype corre-
lated with the eﬀect of overexpression on viability.
Substitutions with Pro (found in bacterial topoisomerase
III at this position) and valine (previously found to
enhance DNA cleavage without aﬀecting viability) were
among those included for comparison. The results
(Table 1) conﬁrmed that the M326R substitution in
YTOP had the most drastic eﬀect on viability, with  4
log lower number of viable colony counts 2h after induc-
tion with arabinose when compared to the non-induced
culture, and >100-fold lower viability ratio than all the
other substitution mutants examined. The cell killing
eﬀect was comparable to the previously characterized
single G122S mutation in the TOPRIM motif (17).
The Arg substitution led tothe loss of>90%
of relaxation activity
Relaxation assays using negatively supercoiled DNA as
substrate (Figure 1) showed that the Arg substitution
resulted in the greatest loss of relaxation activity ( 16-
fold) among the YTOP Met326 substitution mutant pro-
teins puriﬁed and characterized. This suggested that the
cell killing eﬀect of the YTOP-M326R mutant protein
might be due to disruption of the catalytic cycle of the
enzyme. Three other mutant YTOP proteins also had
substitutions bringing in a side chain expected to be fully
charged at physiological pH. The Lys substitution had
the next largest reduction in relaxation activity ( 8-fold).
The Asp and Glu substitutions had a relatively minor eﬀect
on the relaxation activity ( 2–4-fold lower). While the Lys,
Asp, Glu substitutions resulted in some reduction in relax-
ation activity, their eﬀects on viability was >100-fold
lower when compared with the Arg substitution. Wild-
type level relaxation activity was exhibited by the Ser,
Thr and Pro substitution mutant enzymes.
YTOP-M326R and ETOP-M320R had proficient DNA
cleavage activity in thepresence of Mg
2+ but showed
deficiency in DNA religation
To determine the step of the catalytic cycle disrupted by
the Met to Arg substitution, DNA cleavage and religation
activities of YTOP-M326R were analyzed using an oligo-
nucleotide substrate labeled with
32P at the 50-end. DNA
cleavage by wild-type YTOP did not require addition of
Mg
2+. In contrast, cleavage by YTOP-M326R could not
be detected unless Mg
2+ was added to the reaction
(Figure 2A). The cleavage activity of YTOP-M326K
mutant protein was also dependent on added MgCl2.
This dependence of added Mg
2+for DNA cleavage to be
Table 1. Eﬀect of induction of recombinant Y. pestis topoisomerase
I protein (YTOP) with various selected substitutions at Met326 on
viability
Subsitution at Met326 Induced/non-induced relative viability
none 0.17 0.11
Arg 0.00015 0.0.00014
Asn 0.073 0.022
Asp 0.018 0.003
Gln 0.14 0. 09
Glu 0.026 0.005
His 0.18 0.16
Lys 0.042 0.006
Pro 0.075 0.018
Ser 0.081 0.027
Thr 0.13 0.036
Trp 0.017 0.009
Tyr 0.099 0.065
Val 0.11 0.01
Exponential phase cultures of E. coli JD5 transformants were treated
with 0.2% arabinose for 2h at 378C to induce the expression of recombi-
nant YTOP from the BAD promoter. Viable colony counts were deter-
mined by serial dilution and overnight incubation on LB+ampicillin +
2% glucose plates. The number of colonies from the induced culture was
divided by the number of colonies from the control non-induced culture
to obtain the relative viability. The results represent the average and
standard deviation from at least 3 measurements.
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YTOP-G122S. Based on densitometry analysis of results
from three experiments, the amount of cleavage product
observed for YTOP-M326K in the presence of 2mM
MgCl2 was  4-fold lower than that of YTOP-M326R.
For wild-type YTOP addition of 2mM MgCl2 decreased
the level of DNA cleavage product observed because
some of the cleavage product was religated. However,
the level of cleavage product observed for wild-type
YTOP in the presence of 2mM MgCl2 was still around
2-fold higher than that of YTOP-M326K. Rejoining
of DNA cleavage product by wild-type YTOP was both
more rapid, and more complete when compared to YTOP-
M326R (Figure 2B). The rejoining of cleavage product by
YTOP-M326K was also reduced in rate, but was more
complete than YTOP-M326R. DNA cleavage and religa-
tion by the previously characterized YTOP-G122S mutant
was also included in Figure 2 for comparison. While
extent of DNA religation inhibition by the M326R muta-
tion was not as complete as the G122S mutation
(Figure 2B), there was  4-fold more DNA cleavage
product formed in the presence of 2mM Mg(II) by
YTOP-M326R mutant when compared to YTOP-G122S
(Figure 2A). Therefore the level of cleavage complexes
accumulated in vivo by these two mutants may be compa-
rable. These observations reﬂect that DNA cleavage is not
the rate determining step of relaxation, so YTOP-M326K
showed greater relaxation activity than YTOP-M326R
even though DNA cleavage activity was lower for
YTOP-M326K. If DNA rejoining was inhibited, the
extent of DNA cleavage product accumulated in the pre-
sence of Mg
2+ would be expected to correlate with the
observed bactericidal eﬀect due to the prolonged presence
of the covalent cleavage complex in vivo. The amount of
cleavage product accumulated by the YTOP-M326K
mutant topoisomerase I when induced by arabinose
in vivo was probably insuﬃcient to induce the SOS
response and cause much signiﬁcant bacterial cell death.
Even though DNA rejoining by the YTOP-M326R
mutant topoisomerase I was not completely inhibited as
in the case of YTOP-G122S, the higher level of cleavage
complex formed initially still resulted in signiﬁcant extent
YTOP-M326R
S
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YTOP-M326S YTOP-M326T YTOP-M326P
YTOP-M326D YTOP-M326E
ng
ng 
ng 
wild-type YTOP
200 100 50 25 200 100 50 25 12.5
200 100 50 25 12.5
200 100 50 25 12.5 200 100 50 25 12.5 200 100 50 25 12.5
200 100 50 25 12.5 200 100 50 25 12.5
63
Figure 1. Relaxation activity of mutant YTOP proteins with substitutions at Met326. Serial dilutions of wild-type YTOP and mutant YTOP proteins
with diﬀerent substitutions at Met326 were added to 20ml reaction volume of 10mM Tris-HCl, pH 8.0, 50mM NaCl, 0.1mg/ml gelatin, 6mM MgCl2
and 0.5mg of plasmid DNA. Incubation was at 378C for 30min.
Nucleic Acids Research, 2008, Vol. 36, No. 14 4791of overall cleavage complex accumulation and can trigger
the cell-killing process.
The ETOP-M320R mutant protein with the same Met
to Arg substitution as YTOP-M326R was also expressed
and puriﬁed. It exhibited 12–16-fold lower relaxation
activity than wild-type ETOP (Figure 3A). Experiments
with 50-end labeled oligonucleotide substrate (Figure 3B)
showed that DNA cleavage by ETOP-M320R was very
low in the absence of added Mg
2+, but the level of cleav-
age products formed in the presence of 2mM MgCl2
was much higher than that of wild-type ETOP and the
previously characterized ETOP-M320V mutant protein
which had normal DNA religation activity (18). After
addition of high salt to the DNA cleavage reaction,
DNA religation by wild-type ETOP enzyme was extremely
rapid and observed to be complete at 10s (Figure 3C). The
M320R mutation not only aﬀects the level of DNA cleav-
age product that accumulate, but it also takes longer time
(>2min) to reach the maximal level. This longer life time
of the DNA cleavage complex in vivo would then result in
greater level of DNA cleavage complex accumulated on
the chromosome in vivo, making it more likely to initiate
the bactericidal pathway.
Shift in optimal pHfor relaxation activity ofETOP-M320R
The recombinant ETOP-M320R protein had suﬃcient
residual activity to allow the pH proﬁle of the relaxation
reaction to be determined. The results (Figure 4) showed
that wild-type ETOP showed a broad pH optimum
between pH 6.5 and 8.5 as previously reported, with a
symmetrical bell shape curve (24,27). Substitution of
Met320 with Arg resulted in a shift in maximal relaxation
activity to pH 8.5–9.0, and a non-symmetrical bell shape
curve that had a sharp drop-oﬀ in relaxation activity
between pH 9.0 and pH 9.5. This can be interpreted that
while ionization states of the other catalytic residues lim-
ited the enzyme relaxation activity below pH 6.0 or above
pH 9.0, the positive charge of the newly introduced Arg
side chain in ETOP-M320R mutant protein prevented the
relaxation activity except when the electrostatic potential
of the active site region became less positive at the high pH
values. Analysis of the relaxation reaction of products
from ETOP-M320R in agarose gel containing ethidium
bromide (Supplementary Figure 1) showed that the reac-
tion products near the top of the topoisomer ladders
formed at pH 8.5–9.0 corresponded to closed relaxed
DNA, and not nicked DNA molecules. The Arg substitu-
tion probably resulted in increased processivity. Analysis
of the pH dependence of DNA cleavage in the presence
of Mg
2+ also showed a shift to the basic pH values
(Supplementary Figure 2).
Decreased Mg
2+-binding affinity forETOP-320R
due to introduction ofadditional positive charge
into the topoisomerase active site
The positive charge introduced into the active site region
of YTOP and ETOP from the Met to Arg substitution
could aﬀect binding of Mg
2+, and the decrease in Mg
2+
binding aﬃnity would account for the inhibition of DNA
rejoining. To test this hypothesis, binding aﬃnity of
ETOP-M320R was measured by monitoring the decrease
in emission of the intrinsic tryptophan ﬂuorescence upon
binding of Mg
2+ and subsequent conformational change
(28) (Figure 5). The results from curve ﬁtting of three
sets of data for two Mg
2+-binding sites in each enzyme
molecule showed that the dissociation constants calcu-
lated for ETOP-M320R (Kd1=6.4mM, Kd2=348.1mM)
were several fold higher than those reported previously
for wild-type ETOP (Kd1=1.3mM, Kd2=75.2mM)
(18). In contrast, the Met to Val substitution had no sig-
niﬁcant eﬀect on the Mg
2+-binding aﬃnity of ETOP (18).
Modeling ofthe effectof theMet toArg substitution
on the ETOP active site
The Met to Arg substitution was modeled into the pre-
viously determined structure of E. coli topoisomerase I
N-terminal fragment (1ECL). The electrostatic potential
map of the minimized mutant structure (Figure 6) showed
that presence of an arginine residue at position 320 caused
a signiﬁcant increase of positive electrostatic potential and
a decrease of the negative electrostatic potential around
the side chains of the acidic triad of Asp111, Asp113 and
Glu115 responsible for binding of the two Mg
2+ ions.
Figure 2. YTOP-M326R could cleave DNA in the presence of Mg
2+,
but was deﬁcient in DNA rejoining. (A) Magnesium dependence of
DNA cleavage. DNA cleavage product separated by electrophoresis
in a 15% sequencing gel was visualized with the PhosphorImager
after the incubation of 400ng of enzyme ( 4pmol) with 0.5pmol
of oligonucleotide substrate
32P labeled at the 50-end in the presence
of the indicated concentration of MgCl2 at 378C for 30min. (B)
Quantitation of DNA religation. Topoisomerase cleavage reactions in
the presence of 5mM MgCl2 were ﬁrst incubated for 10min. 1M NaCl
was then added to dissociate the enzyme from DNA after religation of
the covalent cleavage complex. Aliquots of the reactions were removed
and stopped with alkaline and formamide at the diﬀerent time points
to assess the extent of religation. The amount of remaining cleavage
product was quantitated after gel electrophoresis with densitometry
analysis. The average and standard deviation from three experiments
are shown here.
4792 Nucleic Acids Research, 2008, Vol. 36, No. 14These changes in electrostatic potential in the active site
region due to the Met to Arg substitution would be
expected to aﬀect the Mg
2+ binding aﬃnity of the
mutant topoisomerase and inhibit DNA religation.
Substitutions of Met326 that increased DNA cleavage
by YTOP
We have previously observed that the Met to Val substitu-
tion in YTOP and ETOP enhanced DNA cleavage with-
out inhibiting DNA religation, and the overall relaxation
activity was maintained at wild-type level (18). The DNA
cleavage activity of the other puriﬁed mutant YTOP pro-
teins included in Figure 2 were analyzed to determine if
any of these substitutions could also enhance the DNA
cleavage by YTOP. YTOP-M326T and YTOP-M326P
were found to form more DNA cleavage products than
wild-type YTOP (Figure 7). The eﬀect of the Thr substitu-
tion was very similar to the Val substitution, with around
2-fold increase in DNA cleavage product in the absence of
added MgCl2. The Pro substitution produced a  3-fold
increase in DNA cleavage in the absence of added MgCl2.
Similar to the Val substitution, the Thr and Pro substitu-
tions did not increase the amount of cleavage product
signiﬁcantly when 2 or 5mM MgCl2 was added to the
cleavage reaction, and the mutations had no eﬀect on
the relaxation activity. Therefore overexpression of these
mutant YTOP proteins did not induce the SOS response
or result in bacterial cell death. Methionine is the con-
served residue at this position for bacterial topoisomerase
I while proline is the conserved residue for bacterial and
eukaryotic topoisomerase III (29).
DISCUSSIONS
Previous work (18) showed that substituting valine for the
conserved methionine adjacent to the active site tyrosine
wild-type ETOP
No
enz 200 100 50 25 12.5 200 100 50 25 12.5 631
A
ng 
ETOP -M320R
C
B No
enz
wt ETOP M320R M320V
Cleavage
Product
0 2 0 2 0 2 mM Mg
Figure 3. Eﬀect of the Met to Arg substitution on ETOP activity. (A) Change in relaxation activity due to the M320R mutation. Relaxation assay
was carried out as described in Figure 1. (B) Comparison of cleavage of 50 32P-labeled oligonucleotide substrate by ETOP, ETOP-M320R and ETOP-
M320V in the absence and presence of added Mg
2+.( C) The extent and rate of DNA religation was reduced for the ETOP-M320R mutant enzyme.
The results represent the average and standard deviation from three experiments.
Nucleic Acids Research, 2008, Vol. 36, No. 14 4793of bacterial topoisomerase I could enhance DNA cleav-
age, indicating that this position can inﬂuence the balance
of cleavage-religation by type IA topoisomerases. In this
study, all possible amino acid substitutions of Met326 of
YTOP were examined in vivo to determine if any amino
acid substitution could induce the SOS response in order
to identify substitutions that could inhibit religation of
DNA. The Arg substitution was the only one found to
induce the SOS response from the dinD1 promoter
in vivo. This mutant topoisomerase had >100-fold greater
eﬀect on cell viability than the other 12 substitution
mutant enzymes that were further characterized for
the consequence of their overexpression on bacterial cell
viability. Biochemical characterization of the puriﬁed
YTOP-M326R and ETOP-M320R mutant topoisomerase
proteins showed that DNA relaxation activity was greatly
reduced because of the eﬀect of Arg substitution on the
DNA religation step. The introduction of an additional
positive charge into the active site region of ETOP due
to the mutation resulted in a shift of the optimal pH for
relaxation activity to higher pH values, indicating an
inhibitory eﬀect from the positive charge of the arginine
side chain. Measurement of the topoisomerase intrinsic
tryptophan ﬂuorescence showed that the arginine substi-
tution reduced the Mg
2+-binding aﬃnity, accounting for
the inhibition of DNA religation. This is consistent with
the molecular modeling results showing the change in elec-
trostatic potential in the active site ETOP-M320R and
decrease of negative electrostatic potential near the
acidic triads responsible for binding two Mg
2+. The
lysine substitution in YTOP also resulted in DNA cleav-
age being Mg
2+ dependent, but the mutation at the same
time signiﬁcantly reduced the level of DNA cleavage pro-
duct formed, thus limiting the degree of in vivo accumula-
tion of covalent complex and the eﬀect of the lysine
substitution on viability.
These results illustrated the critical function of Mg
2+
for completing the catalytic cycle of bacterial topoisom-
erase I relaxation activity. Failure to have the two Mg
2+
occupy the topoisomerase I active site would lead to
in vivo accumulation of the covalent DNA cleavage com-
plex due to inhibition of DNA religation. Genetic studies
showed that in E. coli, the single-stranded break asso-
ciated with the topoisomerase cleavage complex is then
converted to double strand DNA break in the course of
SOS induction (30). The formation of double strand DNA
break would account for the rapid bactericidal eﬀect
observed after induction of the mutant bacterial topo-
isomerase proteins that are defective in DNA religation.
In the ﬁrst examples of such mutant bacterial topoisom-
erase protein, the glycine mutated in YTOP-G122S and
ETOP-G116S is part of the TOPRIM motif directly
involved in interaction with Mg
2+ ions (17). In the case
of YTOP-M326R and ETOP-M320R, the residue mutated
was not part of the Mg
2+-binding motif, but inﬂuenced
Mg
2+binding by altering the active site environment.
Divalent Mg
2+ ions play a critical role in the mecha-
nism of nucleotidyl transferases. The integration of HIV-1
viral DNA into the host chromosome catalyzed by HIV-1
integrase is an important step of the viral life cycle (31).
Small molecule inhibitors of HIV-1 integrase have been
developed into novel anti-viral drugs to combat resistance
of HIV-1 to the older drugs that target HIV-1 reverse
transcriptase and protease (32). Similar to type IA topo-
isomerases, each integrase molecule bind two divalent ions
with the combination of two aspartates and one glutamate
15 ng wild-type ETOP
300 ng ETOP-M320R
No
enz 5.0 5.5 6.0 6.5 7.0 8.0 9.0 9.5 pH  8.5
5.0 5.5 6.0 6.5 7.0 8.0 9.0 9.5 pH  8.5
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Figure 4. The Met to Arg substitution in ETOP shifted the optimal pH
of the relaxation reaction to higher values. Eﬀect of pH on the relaxa-
tion activity of wild-type ETOP (15ng,  0.15pmol) and ETOP-M320R
(300ng,  3pmol) was determined by ﬁrst equilibrating the enzyme
in 5ml with buﬀer of MES (pH 5.0–7.0), Tris (pH 8.0–8.5), or
CHES (pH 9.0–9.5) at 100mM before the addition of 8ml of DNA
(0.5mg,   0.17pmol) plus MgCl2, followed by incubation at 378C
for 30min.
Figure 5. Reduction in Mg
2+-binding aﬃnity as a result of the M320R
substitution in ETOP. Decrease in intrinsic tryptophan ﬂuorescence
upon binding of Mg
2+ measured for wild-type ETOP and ETOP-
M320R was curve ﬁtted for binding of two Mg
2+/enzyme molecule
with the GraphPad Prism program.
4794 Nucleic Acids Research, 2008, Vol. 36, No. 14for catalysis and the divalent ions–enzyme interaction
results in a protein conformational change (31,33,34).
Strand transfer by HIV-1 integrase can be inhibited by
small molecules that chelate the divalent metal ions in
the enzyme active sites (35–37). It might be possible to
target DNA religation by bacterial type IA topoisomerase
employing analogous approaches of interfering with the
divalent metal ion interactions in the enzyme active site.
Even though divalent metal ions have such broad physio-
logical roles, the FDA approval of raltegravir (MK-0518)
that chelates the active site metal ions of HIV-1 integrase
for clinical treatment of AIDS (38) provides evidence that
highly speciﬁc targeting of enzyme–metal ion interaction
can be achieved for therapeutic applications.
Wild-type 
M320R
Y319 Y319
Y319 Y319
M320 M320
R321 R321
D111
D111 D111
D111
D113
D113 D113
D113
E115 E115
E115 E115
R321 R321
R320 R320
Figure 6. Modeling of the electrostatic potential around the active site of ETOP and ETOP-M320R. Stereo view of electrostatic potential maps were
generated with DeepView-Swiss PDB Viewer after energy minimization using a solvent dielectric constant of 80. The maps were contoured at  1.8
kT/e (red)<0.0 kT/e (white)<1.8 kt/e (blue) where k=Boltzmann constant, T=absolute temperature, e=charge of a proton. Residues Asp111,
Asp113, Glu115, Tyr319, Met320/Arg320, Arg321 are shown.
No
Enz
wild-type YTOP YTOP-M326T YTOP-M326P
Cleavage
Product
YTOP-M326V
05 20 5 205 2 0 5 mM Mg 2
Figure 7. Comparison of enhancement of DNA cleavage by Val,
Thr and Pro substitutions at Met326 of YTOP. DNA cleavage
products were analyzed after the incubation of 400ng of enzyme
(4pmol) with 0.5pmol of 50 32P-labeled oligonucleotide substrate
in the presence of the indicated concentration of MgCl2 at 378C for
30min.
Nucleic Acids Research, 2008, Vol. 36, No. 14 4795SUPPLEMENTARY DATA
Supplementary Data are available at NAR Online.
ACKNOWLEDGEMENTS
We are grateful to Prof. James M. Berger at University of
California Berkeley and Mary Coons in his group for
providing us with the TEV protease expression plasmid,
LIC cloning vector and valuable advice. Funding is
provided by National Institutes of Health (GM54226,
AI06933 to Y.T.) Funding to pay the Open Access
publication charges for this article was provided by
National Institutes of Health.
Conﬂict of interest statement. None declared.
REFERENCES
1. Champoux,J.J. (2001) DNA topoisomerases: structure, function,
and mechanism. Annu. Rev. Biochem., 70, 369–413.
2. Wang,J.C. (2002) Cellular roles of DNA topoisomerases: a mole-
cular perspective. Nat. Rev. Mol. Cell Biol., 3, 430–440.
3. Forterre,P., Gribaldo,S., Gadelle,D. and Serre,M.C. (2007) Origin
and evolution of DNA topoisomerases. Biochimie, 89, 427–446.
4. Corbett,K.D. and Berger,J.M. (2004) Structure, molecular
mechanisms, and evolutionary relationships in DNA topoisome-
rases. Annu. Rev. Biophys. Biomol. Struct., 33, 95–118.
5. Liu,L.F. (1989) DNA topoisomerase poisons as antitumor drugs.
Annu. Rev. Biochem., 58, 351–375.
6. Pommier,Y. (2006) Topoisomerase I inhibitors: camptothecins and
beyond. Nat. Rev. Cancer, 6, 789–802.
7. Nitiss,J.L. (2002) DNA topoisomerases in cancer chemotherapy:
using enzymes to generate selective DNA damage. Curr. Opin.
Investig Drugs, 3, 1512–1516.
8. Drlica,K. and Malik,M. (2003) Fluoroquinolones: action and
resistance. Curr. Top. Med. Chem., 3, 249–282.
9. Alekshun,M.N. and Levy,S.B. (2006) Commensals upon us.
Biochem. Pharmacol., 71, 893–900.
10. Dorman,S.E. and Chaisson,R.E. (2007) From magic bullets back to
the magic mountain: the rise of extensively drug-resistant tubercu-
losis. Nat. Med., 13, 295–298.
11. Furuya,E.Y. and Lowy,F.D. (2006) Antimicrobial-resistant bacteria
in the community setting. Nat. Rev. Microbiol., 4, 36–45.
12. Tse-Dinh,Y.C. (2007) Exploring DNA topoisomerases as targets of
novel therapeutic agents in the treatment of infectious diseases.
Infect. Disord. Drug Targets, 7, 3–9.
13. Cheng,B., Liu,I. and Tse-Dinh,Y.C. (2007) Compounds with anti-
bacterial activity that enhance DNA cleavage by bacterial DNA
topoisomerase I. J. Antimicrob. Chemother., 59, 640–645.
14. Aravind,L., Leipe,D.D. and Koonin,E.V. (1998) Toprim – a con-
served catalytic domain in type IA and II topoisomerases, DnaG-
type primases, OLD family nucleases and RecR proteins. Nucleic
Acids Res., 26, 4205–4213.
15. Tse-Dinh,Y.C. (1986) Uncoupling of the DNA breaking and
rejoining steps of escherichia coli type I DNA topoisomerase.
Demonstration of an active covalent protein-DNA complex. J. Biol.
Chem., 261, 10931–10935.
16. Depew,R.E., Liu,L.F. and Wang,J.C. (1978) Interaction between DNA
and escherichia coli protein omega. Formation of a complex between
single-stranded DNA and omega protein. J. Biol. Chem., 253, 511–518.
17. Cheng,B., Shukla,S., Vasunilashorn,S., Mukhopadhyay,S. and
Tse-Dinh,Y.C. (2005) Bacterial cell killing mediated by topoisom-
erase I DNA cleavage activity. J. Biol. Chem., 280, 38489–38495.
18. Cheng,B., Sorokin,E.P. and Tse-Dinh,Y.C. (2008) Mutation
adjacent to the active site tyrosine can enhance DNA cleavage
and cell killing by the TOPRIM gly to ser mutant of bacterial
topoisomerase I. Nucleic Acids Res., 36, 1017–1025.
19. Heitman,J. and Model,P. (1991) SOS induction as an in vivo assay
of enzyme-DNA interactions. Gene, 103, 1–9.
20. Fernandez-Beros,M.E. and Tse-Dinh,Y.C. (1992) Conditional
growth of escherichia coli caused by expression of vaccinia virus
DNA topoisomerase I. J. Bacteriol., 174, 7059–7062.
21. Doyle,S.A. (2005) High-throughput cloning for proteomics research.
Methods Mol. Biol., 310, 107–113.
22. Corn,J.E., Pease,P.J., Hura,G.L. and Berger,J.M. (2005) Crosstalk
between primase subunits can act to regulate primer synthesis in
trans. Mol. Cell, 20, 391–401.
23. Zhu,C.X. and Tse-Dinh,Y.C. (1999) Overexpression and puriﬁca-
tion of bacterial DNA topoisomerase I. Methods Mol. Biol., 94,
145–151.
24. Strahs,D., Zhu,C.X., Cheng,B., Chen,J. and Tse-Dinh,Y.C. (2006)
Experimental and computational investigations of Ser10 and
Lys13 in the binding and cleavage of DNA substrates by
escherichia coli DNA topoisomerase I. Nucleic Acids Res., 34,
1785–1797.
25. Cheng,B., Feng,J., Mulay,V., Gadgil,S. and Tse-Dinh,Y.C. (2004)
Site-directed mutagenesis of residues involved in G strand DNA
binding by escherichia coli DNA topoisomerase I. J. Biol. Chem.,
279, 39207–39213.
26. Guex,N. and Peitsch,M.C. (1997) SWISS-MODEL and the swiss-
PdbViewer: an environment for comparative protein modeling.
Electrophoresis, 18, 2714–2723.
27. Perry,K. and Mondragon,A. (2002) Biochemical characterization
of an invariant histidine involved in escherichia coli DNA topo-
isomerase I catalysis. J. Biol. Chem., 277, 13237–13245.
28. Zhu,C.X. and Tse-Dinh,Y.C. (2000) The acidic triad conserved
in type IA DNA topoisomerases is required for binding of mg(II)
and subsequent conformational change. J. Biol. Chem., 275,
5318–5322.
29. Caron,P.R. (1999) Compendium of DNA topoisomerase sequences.
Methods Mol. Biol., 94, 279–316.
30. Sutherland,J.H., Cheng,B., Liu,I.F. and Tse-Dinh,Y.C. (2008) SOS
induction by stabilized topoisomerase IA cleavage complex occurs
via the RecBCD pathway. J. Bacteriol., 190, 3399–3403.
31. Lewinski,M.K. and Bushman,F.D. (2005) Retroviral DNA
integration – mechanism and consequences. Adv. Genet., 55,
147–181.
32. Pommier,Y., Johnson,A.A. and Marchand,C. (2005) Integrase
inhibitors to treat HIV/AIDS. Nature Rev. Drug Dis., 5, 236–248.
33. Asante-Appiah,E., Seeholzer,S.H. and Skalka,A.M. (1998)
Structural determinants of metal-induced conformational changes
in HIV-1 integrase. J. Biol. Chem., 273, 35078–35087.
34. Asante-Appiah,E. and Skalka,A.M. (1997) Molecular mechanisms
in retrovirus DNA integration. Antiviral Res., 36, 139–156.
35. Kawasuji,T., Fuji,M., Yoshinaga,T., Sato,A., Fujiwara,T. and
Kiyama,R. (2006) A platform for designing HIV integrase inhib-
itors. Part 2: a two-metal binding model as a potential mechanism
of HIV integrase inhibitors. Bioorg. Med. Chem., 14, 8420–8429.
36. Long,Y.Q., Jiang,X.H., Dayam,R., Sanchez,T., Shoemaker,R.,
Sei,S. and Neamati,N. (2004) Rational design and synthesis of novel
dimeric diketoacid-containing inhibitors of HIV-1 integrase: impli-
cation for binding to two metal ions on the active site of integrase.
J. Med. Chem., 47, 2561–2573.
37. Semenova,E.A., Johnson,A.A., Marchand,C., Davis,D.A.,
Yarchoan,R. and Pommier,Y. (2006) Preferential inhibition
of the magnesium-dependent strand transfer reaction of HIV-1
integrase by alpha-hydroxytropolones. Mol. Pharmacol., 69,
1454–1460.
38. Evering,T.H. and Markowitz,M. (2007) Raltegravir (MK-0518):
an integrase inhibitor for the treatment of HIV-1. Drugs Today, 43,
865–877.
4796 Nucleic Acids Research, 2008, Vol. 36, No. 14